Holders — by stockHoldings — by fund
GATES FOUNDATION TRUST
Everything this manager disclosed owning in US-listed stocks — its complete Form 13F portfolio · as of 2026-09-30 · filed with the SEC up to 45 days after quarter end · CIK 0001166559
$29.89B
disclosed book value
25
positions
20.7%
largest position share
Positions, as of 2026-09-30
top 25 of 25 · 13F covers long US-listed positions only — cash, bonds, private and foreign stakes are not disclosed · PUT/CALL tags = options positions (share-equivalents), not shares held
| # | Issuer | Shares | Value | % of book |
|---|---|---|---|---|
| 1 | BRK/BBERKSHIRE HATHAWAY INC DEL | 12.4M | $6.20B | 20.7% |
| 2 | CNICANADIAN NATL RY CO | 51.8M | $6.16B | 20.6% |
| 3 | CATCATERPILLAR INC | 6.4M | $5.15B | 17.2% |
| 4 | WMWASTE MGMT INC DEL | 20.5M | $4.18B | 14% |
| 5 | DEDEERE & CO | 3.6M | $2.39B | 8% |
| 6 | ECLECOLAB INC | 5.2M | $1.43B | 4.8% |
| 7 | WMTWALMART INC | 8.4M | $871.9M | 2.9% |
| 8 | FDXFEDEX CORP | 2.4M | $679.8M | 2.3% |
| 9 | KOFCOCA-COLA FEMSA SAB DE CV | 6.2M | $671.4M | 2.2% |
| 10 | WCNWASTE CONNECTIONS INC | 2.0M | $313.9M | 1.1% |
| 11 | HDHOME DEPOT INC | 1.0M | $284.5M | 1% |
| 12 | MSGSMADISON SQUARE GRDN SPRT COR | 592,406 | $240.0M | 0.8% |
| 13 | SDGRSCHRODINGER INC | 7.0M | $216.8M | 0.7% |
| 14 | WSTWEST PHARMACEUTICAL SVSC INC | 444,500 | $164.8M | 0.6% |
| 15 | DLTRDOLLAR TREE INC | 1.4M | $155.2M | 0.5% |
| 16 | FDXFFEDEX FGHT HLDG CO INC | 1.2M | $130.4M | 0.4% |
| 17 | CPNGCOUPANG INC | 9.2M | $128.3M | 0.4% |
| 18 | BUDANHEUSER BUSCH INBEV SA NV | 1.7M | $125.1M | 0.4% |
| 19 | PCARPACCAR INC | 1.0M | $109.8M | 0.4% |
| 20 | DHRDANAHER CORP DEL | 373,000 | $82.6M | 0.3% |
| 21 | MCDMCDONALDS CORP | 334,900 | $77.3M | 0.3% |
| 22 | KHCKRAFT HEINZ CO | 2.5M | $56.2M | 0.2% |
| 23 | HRLHORMEL FOODS CORP | 2.1M | $41.6M | 0.1% |
| 24 | ONONON HLDG AG | 500,000 | $14.8M | 0% |
| 25 | VLTOVERALTO CORP | 124,333 | $11.7M | 0% |
Source: SEC Form 13F-HR, reporting period 2026-09-30. Values are the manager's filed June-30-style quarter-end marks, not live prices. Research, not investment advice.